Influence of berberine on hyperandrogenism of rats with polycystic ovarian syndrome and StAR protein expression by 郑慧颖 et al.






[4] Szkudelski T.The mechanism of alloxan and streptozotcin actionin 







































Influence of berberine on hyperandrogenism of rats with polycystic ovarian  
syndrome and StAR protein expression
ZHENG Hui-ying1, LI Qing-duan1, CAI Xue-hong1, YE Nan-fang1, HE Ying2
( 1Zhangzhou Hospital of TCM, Zhangzhou 363000, China; 2Experimental Animal Center of Xiamen University,  
Xiamen  361005, China )
通讯作者：郑慧颖，福建省漳州市新浦路2号漳州市中医院，邮编：363000，电话（传真）：0596-2898547，E-mail：896810863@qq.com
• 4231 •中华中医药杂志(原中国医药学报)2017年9月第32卷第9期 CJTCMP , September 2017, Vol . 32, No. 9
Abstract: Objective: To study the therapeutic effect and mechanism of berberine on rats with polycystic ovarian 
syndrome. Methods: Forty-eight six-week SPF female SD rats were randomly divided into blank control group and model 
group. The model group received letrozole to induce PCOS model, then the successful modeling rats undergone were divided 
into model control group, melbine group and berberine group. During the treatment, 1% carboxymethylcellulose was used on 
the blank control group and model control group, 1% carboxymethylcellulose plus melbine were used on the melbine group 
while 1% carboxymethylcellulose plus berberine were used on the berberine group. The testosterone and fasting insulin of 
rats were detected, the ovarian pathological slices of HE staining and the StAR immunohistochemical pathological slices of 
rats were observed under light microscopes. Results: In this experiment, the model rats have typical PCOS manifestations: 
the ovary has polycystic changes; the testosterone rises (P<0.05); the fasting insulin rises (P<0.01), which indicate that 
insulin resistance exists. Both melbine and berberine can improve the insulin resistance of model rats, but the performance of 
berberine in lowering androgen is better than melbine. The testosterone of PCOS hyperandrogenism is positively related to the 
StAR density on the cytomembrane of theca cells. Conclusion: Berberine has effect on PCOS. It can not only improve insulin 
resistance but also treat hyperandrogenism by lowering the StAR density on the cytomembrane of theca cells to decrease 
 the testosterone.
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组别 n 治疗前 治疗后
A组（空白对照组） 11 0.61±0.12 0.79±0.07
B组（模型对照组） 11 22.15±4.61△ 15.19±1.86*△△▲▲
C组（二甲双胍组） 10 21.53±3.37△ 13.96±1.63*△△▲
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